-
Similar remission results shown between once-daily 4g dose and twice-daily 2g doses of mesalazine (PENTASA®) in active ulcerative colitis
in PRESS RELEASE 2011 amResults of a new study 1 presented today at the United European Gastroenterology Week (UEGW) congress in Stockholm demonstrate…
-
Ferring Pharmaceuticals acquires Cytokine PharmaSciences Inc.
in PRESS RELEASE 2011 amFerring Pharmaceuticals (Ferring) announced today that it has completed the purchase of Cytokine PharmaSciences Inc. (CPSI) and its…
PRESS RELEASE 2011
PRESS RELEASE 2011